رجوع
نطاق اليوم
KWD 4.87
KWD 5.39
نطاق 52 أسبوعًا
KWD 1.33
KWD 6.88
حجم التداول
1,733,268
متوسط 50 يوم / 200 يوم
KWD 5.90
/
KWD 4.29
الإغلاق السابق
KWD 5.04
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -11.1 | 0.3 |
| P/B | 3.8 | 2.9 |
| ROE % | -41.3 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 11.000
+106.4%
Low: KWD 9.000
High: KWD 15.000
ربحية السهم المستقبلية
-KWD 0.403
الإيرادات المقدّرة
1.3 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.175
-KWD 0.248 – KWD 4.041
|
650 M | 12 |
| FY2029 |
KWD 0.508
-KWD 0.107 – KWD 1.747
|
400 M | 8 |
| FY2028 |
-KWD 0.059
-KWD 1.727 – KWD 0.853
|
190 M | 14 |
النقاط الرئيسية
Debt/Equity of 0.05 — conservative balance sheet
Negative free cash flow of -49.17M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-41.29%
ROIC-26.44%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.05
Current Ratio15.02
Interest Coverage0.00
التقييم
P/E Ratio
-11.09
P/B Ratio3.75
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -66.49M |
| ROE | -41.29% | ROA | -30.28% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -49.17M |
| ROIC | -26.44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 15.02 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -11.09 | P/B Ratio | 3.75 |
| P/S Ratio | N/A | PEG Ratio | -0.76 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 737.07M | Enterprise Value | 716.25M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 850,000.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -66.49M | -49.38M | -42.49M | -39.23M | -82.18M |
| EPS (Diluted) | -0.42 | -0.36 | -0.33 | -0.35 | -1.31 |
| Gross Profit | 0.0 | 850,000.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -72.84M | -56.63M | -50.36M | -41.66M | -81.88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 219.59M | 140.40M | 156.88M | 199.65M | 153.76M |
| Total Liabilities | 22.80M | 15.17M | 8.34M | 18.01M | 13.68M |
| Shareholders' Equity | 196.79M | 125.23M | 148.54M | 181.64M | 140.08M |
| Total Debt | 9.83M | 6.63M | 1.73M | 2.94M | 4.04M |
| Cash & Equivalents | 30.64M | 43.48M | 24.23M | 34.95M | 144.51M |
| Current Assets | 209.82M | 132.75M | 153.88M | 194.79M | 147.11M |
| Current Liabilities | 13.97M | 8.87M | 7.80M | 16.17M | 10.63M |